CHINA RE Secures Regulatory Nod for Lyu Zhi’s Appointment as Non-Executive Director

Bulletin Express
09/01

On 1 September 2026, China Reinsurance (Group) Corporation (CHINA RE) received confirmation from the National Financial Regulatory Administration (NFRA) approving Mr. Lyu Zhi’s qualification to serve as a director of the company.

Mr. Lyu’s term as a non-executive director, vice-chairman of the Audit Committee and member of the Related-Party Transactions Control Committee commenced retroactively on 26 August 2026 and will run until the current (fifth) Board session ends. He is eligible for re-election upon term expiry. Mr. Lyu recently stepped down as a director of Galaxy Fund Management Co., Ltd. in August 2026.

The company’s Audit Committee currently does not meet Hong Kong Listing Rule 3.21, which requires a majority of independent non-executive directors, as the NFRA has yet to approve Mr. Zhang Xueyong’s qualification as an independent non-executive director. CHINA RE’s Board stated it will take measures to restore full compliance once regulatory approval for Mr. Zhang is obtained.

As of the announcement date, CHINA RE’s Board comprises two executive directors (Mr. Zhuang Qianzhi and Ms. Zhu Xiaoyun), four non-executive directors (Mr. Yang Changsong, Mr. Zhou Zheng, Mr. He Xingda and Mr. Lyu Zhi), and three independent non-executive directors (Mr. Dai Deming, Ms. Ye Mei and Mr. Keung Yui Fai).

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10